Aurochem Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.53 M
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.25 Cr
- Satisfied Charges ₹ 9.51 Cr
- Revenue Growth -7.77%
- Profit Growth 15.42%
- Ebitda 13.46%
- Net Worth 6.02%
- Total Assets 3.59%
About Aurochem Pharmaceuticals (India)
Aurochem Pharmaceuticals (India) Private Limited (APIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 November 1994 and has a history of 30 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.53 M.
The company currently has active open charges totaling ₹30.25 Cr. The company has closed loans amounting to ₹9.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pravinchandra Desai, Pallav Shah, Himanshu Desai, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1994PTC083100
-
Company No.
083100
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 1994
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aurochem Pharmaceuticals (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravinchandra Desai
|
Director | 21-Nov-1994 | Current |
|
Pallav Shah
|
Director | 01-Apr-2015 | Current |
|
Himanshu Desai
|
Director | 08-Feb-2014 | Current |
|
Piyush Shah
|
Director | 21-Nov-1994 | Current |
Financial Performance of Aurochem Pharmaceuticals (India).
Aurochem Pharmaceuticals (India) Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.77% decrease. The company also saw a substantial improvement in profitability, with a 15.42% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurochem Pharmaceuticals (India)?
In 2021, Aurochem Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Regaliz Medicare LimitedPallav Shah, Himanshu Desai and 1 more are mutual person
-
La Pristine Bioceuticals Private LimitedPravinchandra Desai and Piyush Shah are mutual person
-
Aurochem Laboratories (India) Private LimitedPravinchandra Desai, Pallav Shah and 1 more are mutual person
Charges (Loans)
₹302.50 M
₹95.10 M
Charges Breakdown by Lending Institutions
- Others : 30.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2020 | Others | ₹23.75 Cr | Open |
| 19 Dec 2019 | Others | ₹6.50 Cr | Open |
| 10 Jun 2014 | Citi Bank N.A. | ₹5.00 Cr | Satisfied |
| 03 Apr 2001 | State Bank Of India | ₹1.24 Cr | Satisfied |
| 12 Oct 1998 | State Bank Of India | ₹3.27 Cr | Satisfied |
How Many Employees Work at Aurochem Pharmaceuticals (India)?
Aurochem Pharmaceuticals (India) has a workforce of 130 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurochem Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurochem Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
